Czech Republic and Slovakia Electrocardiograph (ECG) Market Size and Share
Market Overview
| Study Period | 2021 - 2032 |
|---|---|
| Forecast Data Period | 2027 - 2032 |
| Base Year Market Size (2026) | USD 10.71 Million |
| Market Size (2027) | USD 11.72 Million |
| Market Size (2032) | USD 18.42 Million |
| Growth Rate (2027 - 2032) | 9.47 % |
| Market Concentration | Medium |
Major Players *Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. | |
Czech Republic and Slovakia Electrocardiograph (ECG) Market Analysis by Mordor Intelligence
The Czech Republic And Slovakia Electrocardiograph Market size is expected to increase from USD 10.71 million in 2026 to USD 11.72 million in 2027 and reach USD 18.42 million by 2032, growing at a CAGR of 9.47% over 2027-2032.
An electrocardiograph (ECG or EKG) is a medical device that records the electrical activity of the heart. In Czechoslovakia, the ECG market is witnessing significant growth, driven by factors such as the increasing prevalence of cardiovascular diseases, advancements in ECG technology, and supportive government policies aimed at improving cardiac health. Additionally, the development of healthcare infrastructure and a growing emphasis on preventative healthcare are expected to further propel the market's expansion in the coming years.
In Czechoslovakia, lifestyle changes, an aging populace, and urbanization have spurred a rise in cardiovascular diseases (CVDs). This uptick has fueled a heightened demand for ECG devices, pivotal for early diagnosis and ongoing monitoring. The European Society of Cardiology's 2023 Atlas of Cardiovascular Disease Statistics spotlighted the Czech Republic's significant cardiovascular challenges, especially with arrhythmias and other heart disorders. Furthermore, the same source noted that 7.1% of adults aged 20–79 grapple with type 1 or type 2 diabetes, a key risk factor for cardiovascular ailments. Such statistics accentuate the surging prevalence of cardiac diseases, bolstering the demand for ECG devices and propelling market growth during the study period.
Government initiatives in the Czech Republic, such as national cardiovascular health programs, have played a pivotal role in enhancing cardiovascular care. These initiatives have not only improved patient outcomes but also contributed to the growth of the ECG market by encouraging the adoption of ECG systems across healthcare facilities.
For example, in December 2024, the Czech government approved the National Cardiovascular Plan, which aims to reduce the prevalence of heart and vascular diseases through improved prevention and care from 2024 to 2033. The plan focuses on strengthening primary prevention, enhancing cardiac monitoring capabilities, modernizing care pathways, and addressing critical challenges such as the shortage of outpatient cardiology resources. These measures are anticipated to drive the adoption of ECG systems in healthcare settings, thereby supporting the market's growth in the years to come.
Moreover, the increasing number of clinical trials utilizing ECG devices to record heart activity is expected to boost the demand for these devices in investigational trials, further driving market growth. For instance, data from ClinicalTrial.gov in February 2025 indicated that Maastricht University initiated a trial in the Czech Republic to evaluate right ventricular pacing and left ventricular septal pacing in conduction disorders using electrocardiograms. Such clinical trials are likely to stimulate the procurement of ECG devices across Czechoslovakia, thereby contributing to the market's expansion.
The growing prevalence of cardiac diseases, combined with supportive government initiatives, is projected to drive the market's growth during the forecast period. However, the high costs associated with advanced ECG devices may pose a challenge, potentially limiting the market's growth trajectory in the country over the same period.
Note: Market numbers in this report are based on Mordor Intelligence's proprietary estimation framework, which combines nine months of actuals with Q4 projections for base year 2026.
Czech Republic and Slovakia Electrocardiograph (ECG) Market Trends and Insights
ECG Management Software Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
The ECG management software segment in Czechoslovakia's electrocardiograph (ECG) market is experiencing significant growth, driven by its essential role in addressing the evolving demands of the healthcare sector. This expansion is attributed to factors such as the increasing need for continuous cardiac monitoring, advancements in ECG software technology, and heightened public awareness regarding cardiovascular health.
Additionally, strategic initiatives by companies to develop innovative ECG management solutions are expected to further accelerate the segment's growth in the coming years. These developments emphasize the segment's critical role in fulfilling the rising demand for accurate and efficient ECG tools within the broader ECG market.
Technological advancements, coupled with the growing integration of artificial intelligence (AI) in developing precise arrhythmia-monitoring ECG software, are anticipated to create substantial growth opportunities for the segment. For instance, in December 2024, Czech-developed software Kardi AI, which utilizes AI to monitor heart rhythms, demonstrated its potential in detecting heart arrhythmias during clinical trials conducted by Ostrava University Hospital.
Designed for use with a chest strap, the software continuously records vital heart data, aiming to enhance patient safety and care. Such technological advancements in ECG software are expected to drive innovation and progress in the country's cardiac monitoring sector in the years ahead.
Moreover, the increasing number of funding activities aimed at developing precise and scalable ECG management software is a key factor propelling the segment's growth. For example, in November 2023, Czech HealthTech startup KARDI AI secured EUR 1.5M (USD 1.55 Mn) in funding to enhance its ECG monitoring tool, shifting its focus from treatment-based solutions to preventive heart activity screening. These funding initiatives are expected to unlock new business opportunities for the market during the forecast period.
In conclusion, advancements in technology, innovations in ECG management tools, and concerted efforts by key industry players to develop scalable cardiac monitoring solutions are projected to drive robust growth in the segment throughout the study period.
The Substantial Rise in Elderly Population is One of the Key Factors Shaping the Market Growth Over the Forecast Period
The growing elderly population in Czechoslovakia, which is more susceptible to cardiovascular diseases, has become a significant driver for the ECG market. This demographic shift is expected to substantially increase the demand for cardiovascular monitoring and diagnostic tools, such as ECG systems, thereby contributing to market growth and improving healthcare service delivery.
The continuous rise in the elderly population across the Czechoslovakia region is anticipated to drive the need for effective cardiac monitoring solutions like ECG systems. Older adults are at a higher risk of developing cardiac conditions compared to younger individuals, further emphasizing the importance of these systems.
For example, the 2024 Aging Report of the Slovak Republic projects that the population aged 65 and above will grow significantly, from 19.5 thousand in 2022 to 22.6 thousand by 2030. This notable increase in the elderly population is expected to encourage investments in advanced heart monitoring technologies, such as ECG systems, thereby fostering market expansion in the coming years.
Therefore, the factors including surge in elderly population and a high risk of elderly population at developing cardiovascular diseases are expected to significantly contribute to the growth of the ECG market during the forecast period.
Competitive Landscape
The competitive landscape of the electrocardiograph (ECG) market in Czechoslovakia is characterized by a mix of established companies and emerging players. The market semi-fragmented yet dynamically competitive. Additionally, many companies offer specialized solutions, contributing to a vibrant and evolving ecosystem. Some of the major players in the market include Norav Medical, Nihon Kohden Corporation, Koninklijke Philips N.V., SCHILLER, among others.
Czech Republic and Slovakia Electrocardiograph (ECG) Industry Leaders
-
Sorimex
-
EGMedical
-
Nihon Kohden Corporation
-
Koninklijke Philips N.V.
-
SCHILLER
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- September 2024: VDI Technologies, an academic startup in Czech Republic successfully achieved ISO 13485 certification, which is essential for marketing its innovative ultra-high frequency ECG technology. This milestone validates the startup's adherence to quality management standards in the development and production of advanced electrocardiography devices.
- February 2023: The International Clinical Research Center in Brno, alongside partners, successfully developed a new high-frequency ECG technology, receiving its second US patent. This innovation enhances diagnostic accuracy, reduces inappropriate treatments, and is currently being experimentally used by 11 hospitals in Europe.
Czech Republic and Slovakia Electrocardiograph (ECG) Market Report Scope
As per the scope of the report, an electrocardiograph (ECG) is a medical device used to record the heart's electrical activity. The device captures the heart's electrical signals and produces a graphical representation known as an electrocardiogram.
The Czechoslovakia ECG market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The China electrocardiograph (ECG) market is segmented by product type, which includes resting (12-lead ECG) systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
| Resting ECG Systems |
| Stress ECG Systems |
| Holter ECG Systems |
| ECG Management Software |
| By Product Type | Resting ECG Systems |
| Stress ECG Systems | |
| Holter ECG Systems | |
| ECG Management Software |
Key Questions Answered in the Report
How big is the Czech Republic And Slovakia Electrocardiograph (ECG) Market?
The Czech Republic And Slovakia Electrocardiograph (ECG) Market size is expected to reach USD 18.42 million in 2027 and grow at a CAGR of 9.47% to reach USD 12.43 million by 2032.
What is the Czech Republic And Slovakia Electrocardiograph (ECG) Market size in 2026?
In 2026, the Czech Republic And Slovakia Electrocardiograph (ECG) Market size accounted for USD 10.71 million.
Who are the key players in Czech Republic And Slovakia Electrocardiograph (ECG) Market?
Sorimex, EGMedical, Nihon Kohden Corporation, Koninklijke Philips N.V. and SCHILLER are the major companies operating in the Czech Republic And Slovakia Electrocardiograph (ECG) Market.
What years does this Czech Republic And Slovakia Electrocardiograph (ECG) Market cover, and what was the market size in 2025?
In 2025, the Czech Republic And Slovakia Electrocardiograph (ECG) Market size was estimated at USD 9.78 million.